Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes

Lipids. 2010 Feb;45(2):129-35. doi: 10.1007/s11745-010-3384-5. Epub 2010 Jan 27.

Abstract

Plasma phospholipid transfer protein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Animal studies have shown that it is closely related to the development of atherosclerosis. Although many studies have indicated that PLTP activity is increased in diabetes mellitus, the role of PLTP in diabetes is still unclear. To evaluate the influence of a high-fat meal on PLTP activity, 50 nondiabetic patients with coronary heart disease (CHD), 50 insulin-treated Type 2 diabetics, and 50 healthy controls were included. We determined PLTP activity before and 4 and 8 h after a high-fat meal. As expected, serum PLTP activity was significantly higher in CHD patients than in healthy controls (71.0 +/- 46.2 vs. 54.0 +/- 33.8 pmol/microl/h, P = 0.032) at baseline. More importantly, we found that serum PLTP activity increased to its maximum 4 h after fat loading and then decreased to nearly basal levels after 8 h both in controls and CHD patients. In contrast, PLTP activity continuously increased during this time period in the diabetic patients. With regards to the data from this study we hypothesize that serum PLTP is involved in the clearance of postprandial lipoproteins and this process is attenuated in diabetes. Since postprandial lipoproteins are atherogenic, the delay in clearance of these particles could play an important role in the development of atherosclerosis in patients with diabetes mellitus.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Atherosclerosis / etiology
  • C-Reactive Protein / metabolism
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Coronary Disease / blood
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Dietary Fats / administration & dosage*
  • Female
  • Humans
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Phospholipid Transfer Proteins / blood*
  • Prospective Studies
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Dietary Fats
  • Insulin
  • Phospholipid Transfer Proteins
  • Triglycerides
  • C-Reactive Protein
  • Cholesterol